Stock 688553 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Huiyu Pharmaceutical Co., Ltd.

Equities

688553

CNE100004ZT4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
13.19 CNY +0.38% Intraday chart for Sichuan Huiyu Pharmaceutical Co., Ltd. -5.11% -12.82%
15/05 China Grants Drug Registration for Huiyu Pharma's Two Injectables MT
26/04 Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Sichuan Huiyu Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of anti-tumor and injection drugs. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The Company's products are mainly used in the clinical treatment of various adaptive diseases. The Company distributes its products both in the domestic market and to overseas markets.

Number of employees: 1,364

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
99.3 %
1,489 99.7 % 921 99.3 % -38.19%
Technical Services
0.6 %
1 0.0 % 6 0.6 % +655.60%
Other
0.1 %
3 0.2 % 1 0.1 % -67.63%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
90.9 %
1,435 96.1 % 843 90.9 % -41.29%
Overseas
9.1 %
58 3.9 % 84 9.1 % +45.79%

Managers

Managers TitleAgeSince
Zhao Ding CEO
 Chief Executive Officer 39 12/10/12
Lan Gao DFI
 Director of Finance/CFO 53 14/19/14
Li Na Ma BRD
 Director/Board Member 48 01/22/01
Yi Dan Zhu IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Li Na Ma BRD
 Director/Board Member 48 01/22/01
Lan Gao DFI
 Director of Finance/CFO 53 14/19/14
Zhao Ding CEO
 Chief Executive Officer 39 12/10/12
Liang Yue BRD
 Director/Board Member 51 01/10/01
Xiao Yang BRD
 Director/Board Member 31 10/20/10
Shu Guang Wang BRD
 Director/Board Member 51 27/19/27
Yong Tan BRD
 Director/Board Member 46 23/12
Ying Wu BRD
 Director/Board Member 51 01/22/01
Ling Deng CHM
 Chairman 40 01/18/01
Chang Jiang Zhang BRD
 Director/Board Member 53 28/22/28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 423,600,000 166,346,440 ( 39.27 %) 0 39.27 %

Shareholders

NameEquities%Valuation
Gan Yi Huang
7.247 %
30,696,852 7.247 % 61 M ¥
Bo Yang
5.002 %
21,190,000 5.002 % 42 M ¥
Xiao Peng Wang
4.022 %
17,037,557 4.022 % 34 M ¥
Yong Ming Cao
4.000 %
16,944,000 4.000 % 34 M ¥
Xun Fan
2.997 %
12,695,629 2.997 % 25 M ¥
Juan Tan
2.884 %
12,215,002 2.884 % 24 M ¥
Fullgoal Fund Management Co., Ltd.
2.450 %
10,379,276 2.450 % 21 M ¥
Shanghai Philip Enterprise Management Center
2.400 %
10,168,467 2.400 % 20 M ¥
Xuzhou Hanyi Enterprise Management Consulting Partnership LP
1.765 %
7,478,498 1.765 % 15 M ¥
Hui Zhen Bao
1.440 %
6,101,134 1.440 % 12 M ¥
NameEquities%Valuation
Zhao Ding
84.89 %
114,066,766 84.89 % 226 M ¥
Neijiang Qiyun Enterprise Management Consulting Co. Ltd.
13.69 %
18,397,865 13.69 % 36 M ¥

Company contact information

Sichuan Huiyu Pharmaceutical Co., Ltd.

Building 3 333, Hanyang Road

641000, Neijiang

+

http://www.huiyupharma.com
address Sichuan Huiyu Pharmaceutical Co., Ltd.(688553)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
SICHUAN HUIYU PHARMACEUTICAL CO., LTD. Stock Sichuan Huiyu Pharmaceutical Co., Ltd.
-12.82% 768M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 754B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 250B
NOVARTIS AG Stock Novartis AG
+11.88% 217B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 216B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688553 Stock
  4. Company Sichuan Huiyu Pharmaceutical Co., Ltd.